StockNews.com upgraded shares of Orthofix Medical (NASDAQ:OFIX – Free Report) from a hold rating to a buy rating in a report published on Friday. Other equities analysts have also recently issued ...

Julie Andrews, Orthofix's CFO, sold 4,655 shares of common stock on Jan. 16, according to a Jan. 21 SEC filing.

Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today announced that it will release its fourth quarter and full-year 2024 financial results on Tuesday, February 25, ...

Canaccord Genuity initiates coverage on Orthofix Medical with a Buy rating and $24 price target, citing growth potential and strong financial outlook.

Stifel has upgraded Orthofix Medical (NASDAQ:OFIX) to buy from hold, citing the company's new management, underappreciated earnings power and cash flow generation. The investment bank said it has ...

Julie Andrews, the Chief Financial Officer of Orthofix Medical (TASE:PMCN) Inc. (NASDAQ:OFIX), recently sold a portion of her holdings in the company. According to a recent filing, Andrews sold 4,655 ...

Orthofix Medical, Inc. engages in the provision of medical devices. It operates through the following business segments: Global Spine and Global Extremities. The Global Spine reporting segment ...

LEWISVILLE, Texas, January 28, 2025--Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today announced that it will release its fourth quarter and full-year 2024 ...